Altria Group Inc. (MO)

44.33
NYSE : Consumer Non-Durables
Prev Close 44.28
Day Low/High 44.14 / 44.56
52 Wk Low/High 39.30 / 66.04
Avg Volume 11.37M
Exchange NYSE
Shares Outstanding 1.87B
Market Cap 82.72B
EPS 3.70
P/E Ratio 13.18
Div & Yield 3.36 (7.46%)

When Everyone Sees the Obvious the Obvious Rarely Happens

Right now it feels as though everyone sees the obvious resistance and overbought situation.

Altria To Host Webcast From The Consumer Analyst Group Of New York Conference

Altria To Host Webcast From The Consumer Analyst Group Of New York Conference

Altria Group, Inc. (Altria) (NYSE: MO) will host a webcast of its business presentation at the annual Consumer Analyst Group of New York conference in Boca Raton, Florida, on Wednesday, February 20, 2019, at approximately 9:00 a.

Altria Rises After Reporting Juul Sales Reached $1 Billion in 2018

Altria Rises After Reporting Juul Sales Reached $1 Billion in 2018

Altria reports mixed fourth-quarter results, matching earnings estimates while missing on revenue.

The Human Response Factor, Fed Moves, China Talks, MSFT Results: Market Recon

The Human Response Factor, Fed Moves, China Talks, MSFT Results: Market Recon

Many see the Fed as done for the year. Never assume. Read the words as they are written.

Altria Reports 2018 Fourth-Quarter And Full-Year Results; Provides 2019 Full-Year Earnings Guidance

Altria Reports 2018 Fourth-Quarter And Full-Year Results; Provides 2019 Full-Year Earnings Guidance

Altria Group, Inc. (Altria) (NYSE:MO) today announces its 2018 fourth-quarter and full-year business results and provides its guidance for 2019 full-year adjusted diluted earnings per share (EPS).

We Finally Got a Down Day and We Probably Need Some More

We should pull back to work off all the short-term indicators that got overbought and after that we should rally again.

Altria Falls After Morgan Stanley Downgrades Shares of the Cigarette Maker

Altria Falls After Morgan Stanley Downgrades Shares of the Cigarette Maker

Morgan Stanley analysts downgrade the stock to underweight.

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.

CEO of PAX Labs Says Cannabis Culture Could Be in For a Makeover

CEO of PAX Labs Says Cannabis Culture Could Be in For a Makeover

Cheech and Chong might need to lose the bong.

Altria To Host Webcast Of 2018 Fourth-Quarter And Full-Year Results

Altria To Host Webcast Of 2018 Fourth-Quarter And Full-Year Results

Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast on Thursday, January 31, 2019, at 9:00 a.

Altria Is a Cold Stock That Could Turn Smoking Hot

Altria Is a Cold Stock That Could Turn Smoking Hot

Altria's recent selloff should be welcomed by both value seekers and those desiring quarterly income to live on.

3 Things to Know at Market Close: Goldman Sachs, PAX Labs, and CBD

3 Things to Know at Market Close: Goldman Sachs, PAX Labs, and CBD

Here's what you need to know on TheStreet.

Is This the Best Large-Cap Stock Out There Now?

Is This the Best Large-Cap Stock Out There Now?

Any logical evaluation of this stock suggests low risk and tremendous upside.

Stubbing Out a Position After Quant Downgrade

We are selling all shares of Altria Group and assigning it to the Bullpen.

Could This Be the Best Large-Cap Stock?

Could This Be the Best Large-Cap Stock?

Any logical evaluation of British American Tobacco suggests low risk and tremendous upside.

Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet

Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet

Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: None Downgrades: DCO, GILT, MO, NCLH Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

How to Trade Cronos, the Cannabis Firm With Ties to Big Tobacco

How to Trade Cronos, the Cannabis Firm With Ties to Big Tobacco

What matters here is the ability to innovate, market, and sell.

A Potential Bottom May Be in Sight for This Portfolio Name

There is no mistaking that Altria Group is in a strong downtrend, but we would suggest adding some shares down here in this selloff.

Trifecta Stocks Weekly Roundup

Because of our inverse ETF positions, the overall portfolio is ahead of the major market indices on a year-to-date basis.

3 Things to Know at Market Close: Tilray, Oil and the Fed

3 Things to Know at Market Close: Tilray, Oil and the Fed

Tilray's deal with InBev gives cannabis new distribution partner, oil tumbles further and more of the top headlines on TheStreet Thursday, Dec. 20.

U.S. Stocks Take a Nosedive as Trump Christmas Shutdown Looms

U.S. Stocks Take a Nosedive as Trump Christmas Shutdown Looms

The Dow is headed for another 52-week low Thursday on concerns over a partial government shutdown and after the Federal Reserve hikes rates for a fourth time this year. After plunging more than 650 points, stocks pared their losses.

Who Hasn't Crashed the Cannabis Party Yet?

Who Hasn't Crashed the Cannabis Party Yet?

Establishing who the stragglers are and what impact they might have in the future is the key at this point.

Tilray Is Now a Top-Tier Cannabis Play

Tilray Is Now a Top-Tier Cannabis Play

I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.

Chart of the Day, Part 1: Tilray, AB Deal Pales in Comparison to Cronos

Chart of the Day, Part 1: Tilray, AB Deal Pales in Comparison to Cronos

The buy-in from other companies into the space has been far larger.

Altria Reaches Agreement to Buy 35% Stake in Juul Labs

Altria Reaches Agreement to Buy 35% Stake in Juul Labs

Altria confirms it is investing $12.8 billion in Juul Labs Inc., the e-cigarette startup.

Fed Hikes Rates, Nike, Altria, Tilray and Pinterest - 5 Things You Must Know

Fed Hikes Rates, Nike, Altria, Tilray and Pinterest - 5 Things You Must Know

U.S. stock futures turn higher Thursday, after the Federal Reserve raises its benchmark lending rate and signals tighter monetary conditions into 2019; Nike and Walgreens report earnings; Altria reportedly is nearing an agreement to buy a 35% stake in Juul Labs; Tilray surges on announcement of partnership with AB InBev.

Altria To Host Webcast To Discuss Altria's Investment In JUUL Labs, Inc.

Altria To Host Webcast To Discuss Altria's Investment In JUUL Labs, Inc.

Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast today at 9:00 a.

Altria Makes $12.8 Billion Minority Investment In JUUL To Accelerate Harm Reduction And Drive Growth

Altria Makes $12.8 Billion Minority Investment In JUUL To Accelerate Harm Reduction And Drive Growth

Altria Group, Inc. (Altria) (NYSE:MO) today announces it signed and closed a $12.

Altria Nears Deal to Take $12.8B Stake in E-Cigarette Maker Juul Labs: Report

Altria Nears Deal to Take $12.8B Stake in E-Cigarette Maker Juul Labs: Report

Parent of Marlboro maker Phillip Morris seeks stake in fast-growing San Francisco startup.

TheStreet Quant Rating: C+ (Hold)